Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsApi holdings

    Api Holdings

    Jump to

    • PharmEasy CEO Siddharth Shah steps down amid string of co-founder exits; Rahul Guha takes over

      Rahul Guha, who currently serves as CEO of subsidiary Thyrocare and President of Operations at API, will take over from Siddharth Shah, the last remaining co-founder of the company, who will now assume the role of Vice Chairman.

    • PharmEasy co-founders Dharmil Sheth, Dhaval Shah, Harsh Parekh and Hardik Dedhia to leave troubled startup

      The founder group cumulatively holds under 2 percent in API Holdings. Each of the five co-founders held between 0.20 percent to 0.30 percent stake in the company, data showed.

    • PharmEasy raises $216 million at a 90% lower valuation from peak

      The online pharmacy was last valued at $5.6 billion in 2021, followed by nearly 90 percent decrease in its valuation amidst debt repayment related challenges.

    • Pharmeasy to seek funding from Manipal only in case of shortfall in rights issue

      The Manipal Group's family office had made a binding offer to invest up to Rs 1,300 crore in the online pharmacy

    • Exclusive | Manipal Group to lead Rs 2,500 crore investment in PharmEasy at massive drop in valuation: Sources

      The Manipal Group family office may also secure a board seat at API Holdings and become its single largest shareholder.

    • Pine Labs and PharmEasy parent hit with valuation markdown by Neuberger Berman

      US-based Neuberger Berman has reduced the fair values of API Holdings and Pine Labs by 21.6 percent and 39 percent, respectively, to $4.39 billion and $3.14 billion, the investor's filings with the Securities and Exchange Commission showed.

    • PharmEasy likely to raise $250 million from General Atlantic, Abu Dhabi fund, CPPIB

      The valuation of India’s largest online pharmacy PharmEasy has dropped to almost half its October 2021 $5.4 billion pre-IPO tag at $2.5-2.75 billion.

    • PharmEasy parent recalls draft IPO papers, weighs rights issue to raise funds

      The rights issue is expected to open for a period of 30 days, starting from on or around the first week of September, API Holdings said.

    • API Holdings falls 44% over 3 months in unlisted market; firm valued at $6.35 billion

      The stock is trading at around Rs 76-78 and is valued at Rs 47,565 crore ($6.35 billion), which analysts feel is still expensive. In October, the firm was reportedly valued at $5.4 billion

    • An unexciting start for Thyrocare-PharmEasy combine

      Thyrocare is trailing peers Dr. Lal PathLabs and Metropolis Healthcare in non-COVID business recovery

    • SEBI gives approval to three more IPOs, including PharmEasy

      These companies that got the nod were API Holdings Ltd, CMR Green Technologies Ltd and Wellness Forever Medicare Ltd.

    • Piramal Capital & Housing Finance ties up with API Holdings

      Piramal Capital & Housing Finance Limited (PCHFL), the wholly-owned subsidiary of Piramal Enterprises Limited, has forged a strategic partnership with API Holdings through its digital platform Retailio, a release said on Thursday.

    • PharmEasy parent API Holdings files DRHP for IPO

      PharmEasy parent API Holdings seeks to raise Rs 6,250 crore via fresh equity issuance.

    • Exclusive | API Holdings, owner of PharmEasy, all set to file DRHP for its IPO next week: Sources

      API Holdings IPO Issue size is likely to be between Rs 6,000 crore and Rs 6,500 crore

    • PharmEasy is just what the doctor ordered for Thyrocare

      Thyrocare has a lean cost structure. But compared to its major diagnostic peers, Thyrocare has lower on-ground (b2c) presence

    • Exclusive | Aditya Puri joins board of PharmEasy’s parent API Holdings ahead of IPO

      The induction of Aditya Puri on the board and acquisition of Medlife is in the run up to the company's IPO. The former head of HDFC bank has been in demand in the corporate world, and will join the board of PNB Housing Finance as an investor nominee, while Strides Group’s Stelis Biopharma announced his appointment as a chairman of the board.

    • TPG looking at 7% stake in Pharmeasy’s parent API Holdings: Report

      In its filing with the CCI, API Holding said it will use this financing to deepen its distribution network across India and build innovative technology-first products for affordable access to healthcare across India.

    • PharmEasy to merge with Medlife, could be valued at $1.2 billion

      Medlife and its promoters will get a 19.59 percent stake in PharmEasy's parent company API Holdings for about $230 million, while PharmEasy holds the remaining 80 percent stake.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347